samenwerkingsverband tussen iwt vlaanderen en het departement economie, wetenschap en innovatie van...

Samenwerkingsverband tussen IWT Vlaanderen en het departement Economie, Wetenschap en Innovatie van de Vlaamse overheid

FP7 research funding opportunities in the field of neuroscience

Alain Deleener - IWTNational Contact Point FP7 Health for Flanders (Belgium)

FP7 funding opportunities for neuroscience

2

EU support for Research and Innovation

complementary programmes, from research to market.

• The €55 billion Seventh Framework Programme supports basic and applied research activities, still far from the market, leverages money and concentrate resources on strategic research areas, always on the basis of technological and scientific excellence.

• The Competitiveness and Innovation Framework Programme does not finance research, but supports innovation activities, provides better access to finance and delivers business support services in the regions.

• Structural funds have just as much funding as FP7, however FP7 concentrates on excellence for competitiveness, while the Structural Funds' main objective is cohesion. However, there are synergies between these programmes.


Cooperation

FP7 Structure and Budget

Ideas (European Research Council)

EC Framework Programme is delineated into four Specific Programmes; total budget of € 50.52 billion

People

Capacities

Cooperation

32,413*

7,51

Ideas

People 4,75

Capacities 4,097

Euratom

4,061JRC (EC)

1,751

*of which Health € 6.1 billion

Total FP7 budget, including EURATOM: € 54,582 billion


4

Collaborative research in FP7:The Cooperation programme

Thematic Priorities1. Health 6.1 2. Food, agriculture, fisheries and biotechnology 1.9

3. Information and communication technologies 9.1 4. Nanosciences, nanotechnologies, materials

and new production technologies 3.5 5. Energy 2.3 6. Environment (including climate change) 1.97. Transport (including aeronautics) 4.28. Socio-economic sciences and the humanities 0.69. Security & 10. Space 2.8

Total for collaborative research €32.4 billion


Collaborative research(Collaborative projects; Networks of Excellence; Coordination/support actions)

Collaborative research(Collaborative projects; Networks of Excellence; Coordination/support actions)

Joint Technology InitiativesJoint Technology Initiatives

Coordination of non-Community research programmes(ERA-NET; ERA-NET+; Article 169)

Coordination of non-Community research programmes(ERA-NET; ERA-NET+; Article 169)

International CooperationInternational Cooperation

•Under each theme there will be sufficient flexibility to address both Emerging needs and Unforeseen policy needs

•Dissemination of knowledge and transfer of results will be supported in all thematic areas

•Support will be implemented across all themes through:

Cooperation – ‘Tools’


6







Scope of research in the Health Theme

• In the Health theme, the Framework programme can support both basic and applied research

• This includes discovery activities, translational research and clinical trials (normally only phase I and II).


Pillar 1:Biotechnology, generic tools

& technologies for health

Pillar 2:Translating research for

human health

Pillar 3:Optimising the delivery

of health care

cross-cutting issues: child health, the health of ageing population gender-related health issues

Budget: € 6.1 billion over 7 years (2007-2013)Health

Biot

ech

Tran

slatio

nal

Publ

ic He

alth

Health research in FP7


High-throughput research technologies for: sequencing (genotyping, phenotyping, gene expression) structural / functional genomics, bioinformatics, systems biology

Predicting suitability, safety and efficacy of therapies pharmacogenomics, biomarkers, targeting and delivery approaches (incl. alternatives to animal testing), and in vivo methods and models

Innovative therapeutic approaches & interventiongene and cell therapy, regenerative medicine, transplantation, immunotherapy and vaccines Bi

otec

h

Tran

slatio

nal

Publ

ic He

alth

Health

Detection, diagnosis and monitoringtools and technologies for: visualisation, imaging, detection and analysis

Health research in FP71: Biotechnology, generic tools and technologies


Integrating biological data and processes large-scale data gathering: generate data to elucidate the function of genes

and gene products and their interaction in complex networks systems biology: to develop and apply systems approaches to understand and model biological processes

Biot

ech

Tran

slatio

nal

Publ

ic He

alth

Health

Research on the brain and related diseases to better understand the integrated structure and dynamics of the brain,

and to study brain diseases, incl age-related ones: dementia, Parkinson

Human development and ageing to better understand the process of life-long development and healthy ageing

Health research in FP72: Translating research for human health (1)


Translational research in infectious diseases: drug resistance HIV / AIDS, malaria, tuberculosis hepatitis new and re-emerging epidemics

Translational research in major diseases: (~ 20-25% of

request) cancer cardiovascular disease diabetes / obesity rare diseases other chronic diseases e.g. rheumatic, respiratory, musculo-skeletal diseases & arthritis)

Biot

ech

Tran

slatio

nal

Publ

ic He

alth

Health

Health research in FP72: Translating research for human health (2)


Translating clinical outcome into clinical practice patient safety, best clinical practice, decision making in clinical settings in primary and specialised care, foster application of evidence-based medicine

Enhanced disease prevention and better use of medicines provide scientific evidence for best public health measures

Biot

ech

Tran

slatio

nal

Publ

ic He

alth

Health

Quality, efficiency and solidarity of health systems organizational, financial and regulatory aspects of health systems

Health research in FP73: Optimising the delivery of health care


Strategy Paper >> DG and Commissioner (Nov.-Dec.‘08)

Reflection paper >> 1st PC meeting (12 January ‘09)

Draft WP >> 2nd PC meeting (5 March ‘09 ?)

Draft WP >> Inter-service Consultation (May)

Draft WP >> PC formal opinion (June)

Work Programme adoption (July)& publication in July or September

Work programme 2010 preparation (4th call)Roadmap


Research priorities for 4th call

Important features:• focus on 4 key research challenges• some areas closed• will probably be split into 2 or 3 calls• 2-stage submission for some areas/topics

focus on 4 Key Research Challenges• Providing tools for translational research• Structuring translational research in the field of

cancer• Structuring translational research in the field of

neurodegenerative diseases.• Better health for Africa


Funding schemes in the Health theme (4th call)

Funding schemes upper limits

Large-scale integrating project (CP-IP) €12m

Network of excellence (NoE) to be specified

Small- or medium-scale focussed research project (CP-FP)

€3m or €6m

Coordination action (CA) €2m

Support action (SA) €0.5m


Biotech, tools & technologies1.1 – High-throughput research1. Harmonisation of phenotyping and biosampling for clinical

research.Funding scheme: Large scale integrating project.

FP7 – Health 4th call topics (1/5)

! Topics communicated with reservation !


Biotech, tools & technologies1.2 – Detection, diagnosis and monitoring1. Tools for the identification and the detection of biomarkers in clinical

samples and patients.• Multimodality biomarker analysis• Tools for detection, isolation and functional characterization of complexes of

interacting molecules for diagnostic purposes• Development of new quantitative imaging biomarker(s) for monitoring

therapeutic effects and safety in chronic diseases• High throughput molecular diagnostic imaging• Development and implementation of quantum imaging of X-rays/Y-rays for

diagnosisFunding scheme: Small or medium-scale focused research projects. (2-stage)




Translating research for health2.1 – Integrating biological data and processes:2.1.2 – Systems biology1. Tackling Human Diseases through Systems Biology Approaches.

Funding scheme: Large-scale integrating projects. (2-stage)2. Creating European multidisciplinary networks to address systems biology

of basic biological processes relevant to health.Funding scheme: Network of Excellence. (2-stage)

3. Coordination and support actions in large-scale data gathering and systems biology.Funding scheme: Coordinating Action.

4. Developing new and improving existing mathematical algorithms for systems biology.Funding scheme: SICA Small or medium-scaled focused research project




Translating research for health2.2.1 – Research on the Brain and related diseases:1. Validation of strategies for treating addiction.

Funding scheme: Large scale integrating project.2. Actions to support dissemination of scientific knowledge in

neuroscience.Funding scheme: Supporting Action.

Also considering possible initiatives linked to Joint Programmingfor research on neurodegenerative diseases.




Translating research for health2.2.2 – Human development and ageing:1. Role of early-life developmental processes in longevity

determination.Funding scheme: Large-scale integrating project. (2-stage)

2. Homeostasis in human development and its effects on lifespan.Funding scheme: Small or medium-scale focused research project. (2-stage)




21







Challenge 2: Cognitive Systems and Robotics Objective ICT-2009.2.1: Cognitive Systems and Robotics

“Pertinent research may be informed by neuro- and behavioural sciences and determine the requirements basic technologies have to meet in order to enable creating the targeted systems.”

FP7 – ICTcall topics (1/4)


Challenge 4: Towards sustainable and personalised healthcare Objective ICT-2009.5.1: Personal Health Systems

Target outcome b): Mental healthICT based solutions for persons suffering from stress, depression or bipolar

disorders (other mental disorders are not in scope).Interdisciplinary research will address the parallel development of technological solutions, as well as new management or treatment models based on closed-loop approaches. Emphasis will be on the use of multiparametric monitoring systems, which monitor various metrics related to behaviour and to bodily and brain functions (e.g. activity, sleep, physiological and biochemical parameters).

Objective ICT-2009.5.3: Virtual Physiological Human“Coordination/Support action to develop an observatory on the achievements and

evolution of the broader Biomedical Informatics field which builds on synergies between bioinformatics, medical informatics, and neuroinformatics. The action should incorporate intensive dissemination and training components and facilitate communication between projects.



Challenge 7: ICT for Independent Living, Inclusion and Governance

Objective ICT-2009.7.2: Accessible and Assistive ICT“ICT restoring and augmenting human capabilities compensating for people with reduced

motor functions or disabilities: Radically new ICT-enabled approaches to restore and augment the ability of people in their daily life with a focus on reduced motor functions. Research should aim for breakthroughs in the way humans interact with computers and how they may overcome their disability and augment their capabilities.

The research should build on progress in non-invasive sensor and actuator concepts for brain/neuronal-computer interaction (BNCI), smart bio-sensors, self-learning/adaptive systems and advanced signal processing.”



4.8 Future and Emerging Technologies (Open call – cut off dates)Radical breakthroughs in ICT increasingly rely on fresh synergies, cross-pollination and convergence with different scientific disciplines (for instance, biology, chemistry, nanoscience, neuro- and cognitive science, ethology, social science, economics) and with the arts and humanities.

Objective ICT-2009.8.4: FET proactive 4: Human-Computer Confluence.

Objective ICT-2009.8.8: FET proactive 8: Brain Inspired ICT Target outcomea) Development of multi-scale models of information processing and

communication in the brain and/or PNS. b) Synthetic Hardware Implementations of Neural Circuits



Next calls in 2009• in June (deadline October/November)• in November (deadline beginning 2010)• every 2 calls all topics will be open

FET : open call with cut off dates

FP7 – ICTfuture calls


FP7: from call to project

Calls proposals

e-proposal evaluationEPSS

ranking

EC decision negotiationGPF-file GA

Project

27


Brussels 30 Jan 2007

28

• Evaluations may follow a single or a two-step evaluation procedure or two-stage submission procedure

• The applicable procedure will be set out in the call

• Two-step evaluation procedure, only proposals that pass the 1st step, based on the evaluation against a limited set of criteria, will go forward for further evaluation

• Two-stage submission procedure, only applicants whose proposals pass the evaluation for the 1st stage will be requested to submit a complete proposal in the 2nd stage

Evaluation & submission procedures



29

Who can participate?

• Any undertaking, university or research centre or other legal entity, whether established in a:

o Member State (MS) o Associated country (Ac) , oro third country

• Joint Research Centre (JRC) - is deemed to be established in another MS or Ac

• International organisations and participants from third countries can participate only if in addition to the minima



30

Conditions for participation

• Minimum condition, general rule, at least 3 independent participants from 3 different MS or Ac

• Additional conditions can be established by the SP or WP (number or type of participant, place of establishment)

• Specific conditions may also apply for:

o Frontier research actions, at least 1 legal entity established in a MS or Ac

o Collaborative projects addressing the participation of International Cooperation Partner Countries (ICPC) minimum is 4 participants, 2 of which from MS or Ac and another 2 from ICPC countries unless otherwise foreseen in the WP



31

Criteria for evaluation

• The Commission will evaluate the proposals submitted according to the following main criteria:

o Scientific and/or technological excellence

o relevance to the topic of the call

o quality and efficiency of the implementation and management

o potential impact of project results

• Additional requirements on the application of these criteria may be added in the work programmes

• For research actions under the IDEAS Programme the sole criterion of excellence will apply



32

Eligibility for funding

• Legal entities from MS and Ac or created under Community law and the JRC

• International European interest organisations

• Legal entities established in international cooperation partner countries (ICPC), and

• International organisations and legal entities from third countries other than ICPC only if:

o provided for in SP or WP; or

o their contribution is essential for carrying out action; or

o provision for funding is provided for in a bilateral agreement between Community and the third country



33

Upper funding limits

Reimbursement will be according to the type of action and/or activity• Research and technological development activities: up to 50% of eligible

costs, or up to 75% for:• Non profit public bodies • secondary and higher education establishments• research organisations• SMEs• Security related research, for highly reliable capabilities with impact on

security of European citizens and targeted to a limited number of public users

• Demonstration activities: up to 50%• Other activities including management: up to 100%• Actions that will be reimbursed up to 100%:

• Frontier research• Coordination and support• Training and career development of researchers



34

Reimbursement of eligible costs

• Most funding schemes use reimbursement of eligible costs

o Eligible

actual (average personnel costs may be used if do not differ significantly from actual)

incurred during duration of project

in accordance with the beneficiary usual accounting and management principles

recorded in the accounts of beneficiary

used for the sole purpose of achieving the objectives of the project

o Non-eligible (identifiable indirect taxes including VAT…)



35

Indirect Cost

• Participants may charge eligible direct and indirect costs

• Reimbursement of indirect costs :o For all:

either actual overhead, or simplified method, or flat rate of 20% of direct costs

o For Non profit Public Bodies, Secondary and Higher Education establishments, Research Organisations, and SMEs unable to identify real indirect costs, may apply for a flat rate of 60% for funding schemes with Research, Technological Development & Demonstration

o For Coordination and Support Actions limit of 7% of direct costs


36

• Match your objectives with the Programme funding opportunities. Have a clear vision of what you want to get.

• Do it only if it corresponds to your strategic goals.

• Use the various supporting options….

How to use FP7 Do and don’t…


Consortium size and composition

There is no ideal size: whether it is for small, medium or large proposals, the consortium must be composed of the right set of competences and resources large Integrating projects do not necessarily require large consortia there are not “political” / “geographical” requirements, although there should not be obvious imbalances

eg: 5 out of 7 partners from same country


Key factors for success in applying for FP7 funding

Competition is tough: only the best projects get funded

The proposal must be in scope with the topic and the work programme (not wishful thinking)

The consortium of partners must be excellent and appropriate for the task (select the right partners)

The proposal must address all 3 criteria

Convince the evaluators (don’t rely on reputation)

and, of course, respect the basic rules (deadlines, n° participants, ceilings, length, ethics, …)

samenwerkingsverband tussen iwt vlaanderen en het departement economie, wetenschap en innovatie van...

Documents

fp7 funding opportunities

fp7 concentrates

total fp7 budget

applied research activities

strategic research areas

cooperation tools slide

innovation framework

international cooperation